{"resourceType":"Condition","id":"8959","meta":{"versionId":"2","lastUpdated":"2022-12-21T15:09:01.697+01:00","source":"#URfhUQxyVzfGpQjD","profile":["http://hl7.eu/fhir/ig/pcsp/StructureDefinition/Condition-primaryCancer-eu-pcsp"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/condition-assertedDate","valueDateTime":"2017-08-22"},{"url":"http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-histology-morphology-behavior","valueCodeableConcept":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/icd-o-3","code":"9826/3"}]}}],"code":{"text":"pre-B ŪLL, SRG, CNS1, REMISIJA"},"bodySite":[{"extension":[{"url":"http://hl7.eu/fhir/ig/pcsp/StructureDefinition/mcode-laterality-qualifier","valueCodeableConcept":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/data-absent-reason","code":"not-applicable"}]}}],"coding":[{"system":"http://terminology.hl7.org/CodeSystem/icd-o-3","code":"C42.0"}],"text":"B pirmtakų limfoblastinė leukemija"}],"subject":{"reference":"Patient/8958"},"stage":[{"summary":{"text":"Standartinė rizikos grupė (SRG), CNS1"}}],"evidence":[{"code":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/iccc-3","code":"001"}]}]},{"code":[{"coding":[{"system":"http://snomed.info/sct","code":"32895009","display":"Hereditary disease"}],"text":"HIPERDIPLOIDINIS KARIOTIPAS"}]}],"note":[{"text":"SNP-A tyrimas - hiperdiploidinis kariotipas 50,XXY (4,6,10,18 chromosomų trisomijos), su 21q duplikacija ir 12, 13, 20 chromosomų heterozigotiškumo praradimu.\r\n"}]}
